Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-02-16
1999-12-07
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548486, A01N 4338, C07D20934
Patent
active
059984635
ABSTRACT:
This invention relates to certain 5-acyl-2-oxo-indole-3-carboxamides useful as inhibitors of glycogen phosphorylase, methods of treating glycogen phosphorylase dependent diseases or conditions with such compounds and pharmaceutical compositions comprising such compounds. This invention also relates to pharmaceutical compositions comprising those 5-acyl-2-oxo-indole-3-carboxamides in combination with antidiabetes agents and methods of treating glycogen phosphorylase dependent diseases or conditions with such compositions.
Hulin Bernard
Sarges Reinhard
Benson Gregg C.
Gammill Martha A.
Keating Dominic
Pfizer Inc
Richardson Peter C.
LandOfFree
Glycogen phosphorylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycogen phosphorylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycogen phosphorylase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-824482